JP2023518829A5 - - Google Patents
Info
- Publication number
- JP2023518829A5 JP2023518829A5 JP2022557164A JP2022557164A JP2023518829A5 JP 2023518829 A5 JP2023518829 A5 JP 2023518829A5 JP 2022557164 A JP2022557164 A JP 2022557164A JP 2022557164 A JP2022557164 A JP 2022557164A JP 2023518829 A5 JP2023518829 A5 JP 2023518829A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- subject
- effect
- lowering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062994486P | 2020-03-25 | 2020-03-25 | |
| US62/994,486 | 2020-03-25 | ||
| PCT/US2021/023497 WO2021194975A1 (en) | 2020-03-25 | 2021-03-22 | Method for treating diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518829A JP2023518829A (ja) | 2023-05-08 |
| JP2023518829A5 true JP2023518829A5 (https=) | 2024-03-29 |
Family
ID=77890597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022557164A Pending JP2023518829A (ja) | 2020-03-25 | 2021-03-22 | 糖尿病の治療方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12569463B2 (https=) |
| EP (1) | EP4132505A4 (https=) |
| JP (1) | JP2023518829A (https=) |
| CN (1) | CN115279363A (https=) |
| AU (1) | AU2021244313A1 (https=) |
| MX (1) | MX2022011651A (https=) |
| WO (1) | WO2021194975A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115089572A (zh) * | 2022-07-18 | 2022-09-23 | 南通大学 | 一种化合物olt1177在制备治疗2型糖尿病药物制剂中的应用 |
| CN119632971A (zh) * | 2024-09-10 | 2025-03-18 | 浙江大学 | 一种达泮舒腈的应用及药物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2970485T3 (es) * | 2017-01-06 | 2024-05-29 | Olatec Therapeutics Llc | Composición farmacéutica para su uso en el tratamiento de enfermedades cardiovasculares |
| WO2018204764A1 (en) * | 2017-05-05 | 2018-11-08 | Camp4 Therapeutics Corporation | Identification and targeted modulation of gene signaling networks |
| CN111094242B (zh) * | 2017-07-24 | 2024-02-09 | 诺华股份有限公司 | 用于治疗与nlrp活性相关的病症的化合物和组合物 |
-
2021
- 2021-03-22 EP EP21774979.5A patent/EP4132505A4/en active Pending
- 2021-03-22 MX MX2022011651A patent/MX2022011651A/es unknown
- 2021-03-22 AU AU2021244313A patent/AU2021244313A1/en active Pending
- 2021-03-22 CN CN202180020954.7A patent/CN115279363A/zh active Pending
- 2021-03-22 WO PCT/US2021/023497 patent/WO2021194975A1/en not_active Ceased
- 2021-03-22 JP JP2022557164A patent/JP2023518829A/ja active Pending
-
2022
- 2022-09-22 US US17/934,526 patent/US12569463B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022009125A5 (https=) | ||
| JP2024540183A5 (https=) | ||
| JP2015164964A5 (https=) | ||
| JP2007514750A5 (https=) | ||
| JP2021035998A5 (https=) | ||
| ITMI952337A1 (it) | Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo | |
| RU2007104095A (ru) | Применение твердой пероральной дозировочной композиции пролонгированного действия для приготовления лекарственных средств | |
| EA015382B1 (ru) | Применение рофлумиласта для лечения сахарного диабета типа 2 | |
| JP2023115271A5 (https=) | ||
| JP2023518829A5 (https=) | ||
| JP2020100623A (ja) | 炎症及び疼痛の治療のための組成物及び方法 | |
| CN102149377A (zh) | 决奈达隆在制备用于预防中风或短暂性缺血发作的药物中的用途 | |
| BR112019026029A2 (pt) | Formulações farmacêuticas orais de remogliflozina | |
| CN101642443B (zh) | 单硝酸异山梨酯渗透泵型控释制剂及其制备方法 | |
| WO2008057464A2 (en) | Compositions and methods for improving the bioavailability of liothyronine | |
| WO2013026270A1 (zh) | 右布洛芬左西替利嗪缓释双层片在治疗气道炎症中的用途 | |
| CN111467348A (zh) | 一种n-(噻唑-2-基)-3-(哌嗪-1-基)丙酰胺类衍生物在药物制备中的应用 | |
| CN121398832A (zh) | 用于药物疗法的司美格鲁肽 | |
| KR20230143978A (ko) | 시클로-히스프로를 유효성분으로 포함하는 당뇨병 예방 또는 치료용 약제학적 제제 | |
| EP3220911B1 (en) | Levosimendan for use as a liver protector | |
| JP2025522146A5 (https=) | ||
| JP6698669B2 (ja) | 粘膜炎の治療のための組成物及び方法 | |
| JP2024506041A5 (https=) | ||
| BRPI0713647A2 (pt) | formulações farmacêuticas e composições de um antagonista seletivo cxcr2 ou cxcr1 e métodos para o uso do mesmo visando o tratamento de distúrbios inflamatórios | |
| US20220233508A1 (en) | Pharmaceutical composition comprising famotidine, lidocaine and melatonin |